Accessibility Menu
Fresenius Medical Care logo

Fresenius Medical Care(OTC) FMCQF

Market Cap$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-16%
5 Year-25%
1 Year+5%
1 Month+15%
$51.44
+3.25%
+1.62Today
Fresenius Medical Care last closing stock price
MetricPriceDate
Last closeUSD 51.442026-08-03
Fresenius Medical Care stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.3%USD 48.852026-07-23
1 month+15.36%USD 44.592026-07-02
3 month+24.53%USD 41.312026-05-05
Year to date+15.32%USD 44.612025-12-18
1 year+5.08%USD 48.952025-08-01
3 year+13.98%USD 45.132023-08-01
5 year-25.3%USD 68.862021-08-03
Since inception-16.4%USD 61.532003-12-08

Fresenius Medical Care Financials at a Glance

Market Cap

$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€19.44B

Net Income (TTM)

€937.80M

EPS (TTM)

$3.88

P/E Ratio

13.27

Dividend

$1.73

Beta (Volatility)

0.07 (Low)

Price

$51.44

Volume

159

Open

$51.44

Previous Close

$51.44

Daily Range

$51.44 - $51.44

52-Week Range

$42.00 - $56.24

Estimated Earnings Date

Nov 3, 2026

FMCQF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Fresenius Medical Care

Fresenius Medical Care AG is a leading provider of products and services for individuals with renal diseases. The company operates through two main segments: Care Enablement and Care Delivery, focusing on healthcare products and services for chronic kidney disease (CKD) and end-stage renal disease (ESRD).

Products and Services
  • Healthcare products for renal disease management
  • Value and risk-based care programs
  • Extracorporeal therapies and treatment services
Growth Outlook
  • Strong demand for renal care services is expected to drive growth
  • Expansion into emerging markets presents significant opportunities
  • Investment in R&D aims to enhance product offerings and efficiency
Financial Highlights
  • Recent quarterly revenue of €4.63 billion reflects steady performance
  • Trailing twelve months (TTM) net income of €164.76 million shows resilience
  • TTM dividend yield of 3.53% indicates attractive returns for investors
Fresenius Medical Care AG is well-positioned in the healthcare sector, particularly in the renal care market. The company's dual focus on product innovation and service delivery enhances its competitive edge. Recent financial performance indicates stability, with a solid revenue base and a commitment to shareholder returns through dividends. The growth outlook remains positive, driven by increasing demand for renal care and strategic investments in new markets and technologies. This combination of factors makes Fresenius Medical Care AG an intriguing option for potential investors interested in the healthcare industry.
AI Generated • Jul 17, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

107,226

CEO

Helen Giza, MBA

Website

www.freseniusmedicalcare.com/de

Headquarters

Bad Homburg, HE 61352, DE

FMCQF Financials

Key Financial Metrics (TTM)

Gross Margin

26.36%

Operating Margin

10.69%

Net Income Margin

4.83%

Return on Equity

7.21%

Return on Capital

7.62%

Return on Assets

3.00%

Earnings Yield

7.54%

Dividend Yield

3.36%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

266.11M

Volume

159

Avg. Volume

6.76K

Financials (TTM)

Gross Profit

€5.12B

Operating Income

€1.95B

EBITDA

€3.41B

Operating Cash Flow

€2.83B

Capital Expenditure

-€1.05B

Free Cash Flow

€1.79B

Cash & ST Invst.

€1.45B

Total Debt

€10.96B

Fresenius Medical Care Performance Analysis

Fresenius Medical Care annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 20,383,982,131-2.1%
20232023-12-31EUR 21,032,149,4313.2%
20242024-12-31EUR 20,917,464,341-0.5%
20252025-12-31EUR 22,161,735,1155.9%
Fresenius Medical Care sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.9%
Q42025-12-313.8%
Q12026-03-31-8.7%
Q22026-06-304.8%
Fresenius Medical Care annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 2.41-38.3%
20232023-12-31EUR 1.84-23.8%
20242024-12-31EUR 1.987.9%
20252025-12-31EUR 3.7991.2%
Fresenius Medical Care sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3022.1%
Q42025-12-3121.3%
Q12026-03-31-62.3%
Q22026-06-3088.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€4.85B

+1.3%

Gross Profit

€1.31B

+7.7%

Gross Margin

26.95%

N/A

Market Cap

$13.69BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$123.29K

N/A

Employees

111,024

N/A

Net Income

€217.67M

-3.4%

EBITDA

€843.66M

+2.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€1.45B

-33.8%

Total Debt

€10.96B

-0.6%

Accounts Receivable

€3.47B

+7.2%

Inventory

€2.33B

+16.8%

Long Term Debt

€8.64B

-8.3%

Short Term Debt

€2.33B

+45.0%

Return on Assets

3.00%

N/A

Return on Invested Capital

8.61%

N/A

Free Cash Flow

€619.90M

-0.1%

Operating Cash Flow

€860.30M

+11.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GIKLYGrifols, S.A.
$5.10+0.00%
SNNUFSmith & Nephew plc
$15.48+0.00%
SBMFFSino Biopharmaceutical Limited
$0.61+0.00%
SONVYSonova Holding AG
$59.01+0.68%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About FMCQF

What is the current price of Fresenius Medical Care?

Fresenius Medical Care is trading at $51.44 per share.

What is the 52-week range for Fresenius Medical Care?

Over the past 52 weeks, Fresenius Medical Care has traded between $42.00 and $56.24.

How much debt does Fresenius Medical Care have?

As of the most recent reporting period, Fresenius Medical Care reported total debt of €12.53B.

How much cash does Fresenius Medical Care have on hand?

Fresenius Medical Care reported €1.21B in cash and cash equivalents in its most recent financial results.

What is Fresenius Medical Care’s dividend yield?

Fresenius Medical Care currently has a dividend yield of 3.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services